Local failure after complete resection of N0-1 non-small cell lung cancer

Lung Cancer

Volumn 71, Issue 2, 2011, Pages 156-165

  Saynak, Mert ^a,d   Veeramachaneni, Nirmal K ^b   Hubbs, Jessica L ^a   Nam, Jiho ^a   Qaqish, Bahjat F ^c   Bailey, Janet E ^a   Chung, Wonil ^c   Marks, Lawrence B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c IL   (United States)

^d TRAKYA UNIVERSITY   (Turkey)

Author keywords

Distant failure; Local regional failure; Non small cell lung cancer; Patterns of failure; Postoperative radiotherapy; Surgery

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LARGE CELL CARCINOMA; LOBECTOMY; LOG RANK TEST; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MEDICAL RECORD REVIEW; PLEURA; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SATELLITE CELL; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 78650940701     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.06.001     Document Type: Article

References (48)

1. Rena O., Oliaro A., Cavallo A., Filosso P.L., Donati G., Di Marzio P., et al. Stage I non-small cell lung carcinoma: really an early stage?. Eur J Cardiothorac Surg 2002, 21:514-519.
2. Kelsey C.R., Marks L.B., Hollis D., Hubbs J.L., Ready N.E., D'Amico T.A., et al. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer 2009, 115:5218-5227.
3. Fujimoto T., Cassivi S.D., Yang P., Barnes S.A., Nichols F.C., Deschamps C., et al. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival. J Thorac Cardiovasc Surg 2006, 132:499-506.
4. Arriagada R., Dunant A., Pignon J.P., Bergman B., Chabowski M., Grunenwald D., et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004, 350:351-360.
5. Douillard J.Y., Rosell R., De Lena M., Carpagnano F., Ramlau R., Gonzáles-Larriba J.L., et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006, 7:719-727.
6. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. The Lung Cancer Study Group. N Engl J Med 1986;315:1377-81.
7. Stephens R.J., Girling D.J., Bleehen N.M., Moghissi K., Yosef H.M., Machin D. The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party. Br J Cancer 1996, 74:632-639.
8. Mayer R., Smolle-Juettner F.M., Szolar D., Stuecklschweiger G.F., Quehenberger F., Friehs G., et al. Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest 1997, 112:954-959.
9. Van Houtte P., Rocmans P., Smets P., Goffin J.C., Lustman-Maréchal J., Vanderhoeft P., et al. Postoperative radiation therapy in lung caner: a controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys 1980, 6:983-986.
10. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet 1998;352:257-63.
11. Postoperative radiotherapy for non-small cell lung cancer. PORT Meta-analysis Trialists Group. Cochrane Database Syst Rev 2005:CD002142.
12. Trodella L., Granone P., Valente S., Valentini V., Balducci M., Mantini G., et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol 2002, 62:11-19.
13. Edge S.B., Byrd D.R., Compton C.C., Fritz A.G., Greene F.L., Trotti A. AJCC cancer staging manual 2009, Springer, New York. 7th ed.
14. Pieterman R.M., van Putten J.W., Meuzelaar J.J., Mooyaart E.L., Vaalburg W., Koëter G.H., et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000, 343:254-261.
15. Vansteenkiste J.F., Stroobants S.G., Dupont P.J., Mortelmans L.A., De Leyn P.R., Verschakelen J.A., et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998, 16:2142-2149.
16. Schraube P., von Kampen M., Oetzel D., Sroka G., Wannenmacher M. The impact of 3-D radiotherapy planning after a pneumonectomy compared to a conventional treatment set-up. Radiother Oncol 1995, 37:65-70.
17. Graham M.V., Purdy J.A., Emami B., Harms W., Bosch W., Lockett M.A., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999, 45:323-329.
18. Marks L.B., Munley M.T., Bentel G.C., Zhou S.M., Hollis D., Scarfone C., et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 1997, 39:563-570.
19. Sawyer T.E., Bonner J.A., Gould P.M., Foote R.L., Deschamps C., Lange C.M., et al. Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma. Ann Thorac Surg 1999, 68:1171-1176.
20. Kim Y.T., Kang C.H., Sung S.W., Kim J.H. Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy. Ann Thorac Surg 2005, 79:1153-1160. discussion 1160-61.
21. Lardinois D., Suter H., Hakki H., Rousson V., Betticher D., Ris H.B. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg 2005, 80:268-274. discussion 274-5.
22. Wu Y., Huang Z.F., Wang S.Y., Yang X.N., Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002, 36:1-6.
23. Allen M.S., Darling G.E., Pechet T.T., Mitchell J.D., Herndon J.E., Landreneau R.J., et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006, 81:1013-1019. [discussion 1019-20].
24. Pignon J.P., Tribodet H., Scagliotti G.V., Douillard J.Y., Shepherd F.A., Stephens R.J., et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008, 26:3552-3559.
25. Dunant A., Pignon J.P., Le Chevalier T. Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial. Clin Cancer Res 2005, 11:5017-5021.
26. Scagliotti G.V., Fossati R., Torri V., Crinò L., Giaccone G., Silvano G., et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. J Natl Cancer Inst 2003, 95:1453-1461.
27. Waller D., Peake M.D., Stephens R.J., Gower N.H., Milroy R., Parmar M.K., et al. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Eur J Cardio-Thorac Surg 2004, 26:173-182.
28. Douillard J.Y., Rosell R., De Lena M., Riggi M., Hurteloup P., Mahe M.A., et al. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Int J Radiat Oncol Biol Phys 2008, 72:695-701.
29. Lafitte J.J., Ribet M.E., Prévost B.M., Gosselin B.H., Copin M.C., Brichet A.H. Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study. Ann Thorac Surg 1996, 62:830-834.
30. Debevec M., Bitenc M., Vidmar S., Rott T., Orel J., Strojan P., et al. Postoperative radiotherapy for radically resected N2 non-small-cell lung cancer (NSCLC): randomised clinical study 1988-1992. Lung Cancer 1996, 14:99-107.
31. Dautzenberg B., Arriagada R., Chammard A.B., Jarema A., Mezzetti M., Mattson K., et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma, Groupe d'Etude et de Traitement des Cancers Bronchiques. Cancer 1999, 86:265-273.
32. Watanabe Y., Shimizu J., Tsubota M., Iwa T. Mediastinal spread of metastatic lymph nodes in bronchogenic carcinoma, Mediastinal nodal metastases in lung cancer. Chest 1990, 97:1059-1065.
33. Kelsey C.R., Light K.L., Marks L.B. Patterns of failure after resection of non-small-cell lung cancer: implications for postoperative radiation therapy volumes. Int J Radiat Oncol Biol Phys 2006, 65:1097-1105.
34. Miles E.F., Kelsey C.R., Kirkpatrick J.P., Marks L.B. Estimating the magnitude and field-size dependence of radiotherapy-induced mortality and tumor control after postoperative radiotherapy for non-small-cell lung cancer: calculations from clinical trials. Int J Radiat Oncol Biol Phys 2007, 68:1047-1052.
35. Ichinose Y., Kato H., Koike T., Tsuchiya R., Fujisawa T., Shimizu N., et al. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials. Lung Cancer 2001, 34:29-36.
36. Varlotto J.M., Recht A., Flickinger J.C., Medford-Davis L.N., Dyer A.M., Decamp M.M. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer. Cancer 2009, 115:1059-1069.
37. Ginsberg R.J., Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer, Lung Cancer Study Group. Ann Thorac Surg 1995, 60:615-622. [discussion 622-3].
38. Feld R., Rubinstein L.V., Weisenberger T.H. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J Clin Oncol 1984, 2:1352-1358.
39. Kato H., Ichinose Y., Ohta M., Hata E., Tsubota N., Tada H., et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004, 350:1713-1721.
40. Bedini A.V., Cataldo I., Valente M., Ravasi G. Five-year recurrence probabilities in 330 patients curatively resected for stage Ia bronchogenic carcinoma. Tumori 1987, 73:131-137.
41. Sawyer T.E., Bonner J.A., Gould P.M., Deschamps C., Lange C.M., Li H. Patients with stage I non-small cell lung carcinoma at postoperative risk for local recurrence, distant metastasis, and death: implications related to the design of clinical trials. Int J Radiat Oncol Biol Phys 1999, 45:315-321.
42. Harpole D.H., Herndon J.E., Young W.G., Wolfe W.G., Sabiston D.C. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995, 76:787-796.
43. Martini N., Bains M.S., Burt M.E., Zakowski M.F., McCormack P., Rusch V.W., et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995, 109:120-129.
44. Immerman S.C., Vanecko R.M., Fry W.A., Head L.R., Shields T.W. Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure. Ann Thorac Surg 1981, 32:23-27.
45. Gauger J., Patz E.F., Coleman R.E., Herndon J.E. Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrence. J Thorac Oncol 2007, 2:499-505.
46. Feng Q.F., Wang M., Wang L.J., Yang Z.Y., Zhang Y.G., Zhang D.W., et al. A study of postoperative radiotherapy in patients with non-small-cell lung cancer: a randomized trial. Int J Radiat Oncol Biol Phys 2000, 47:925-929.
47. Luzzi L., Voltolini L., Campione A., Paladini P., Ghiribelli C., Di Bisceglie M., et al. Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: could the type of surgical resection dictate survival?. J Cardiovasc Surg (Torino) 2003, 44:119-123.
48. Matsuoka K., Sumitomo S., Misaki N. Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung. J Thorac Oncol 2007, 2:1098-1102.